LIVANOVA PLC (LIVN)
GB00BYMT0J19 - Common Stock
We assign a fundamental rating of 4 out of 10 to LIVN. LIVN was compared to 192 industry peers in the Health Care Equipment & Supplies industry. LIVN has only an average score on both its financial health and profitability. LIVN has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
LIVN had positive earnings in the past year.
LIVN had a positive operating cash flow in the past year.
In the past 5 years LIVN reported 4 times negative net income.
The reported operating cash flow has been mixed in the past 5 years: LIVN reported negative operating cash flow in multiple years.
1.2 Ratios
LIVN has a Return On Assets of 0.73%. This is in the better half of the industry: LIVN outperforms 72.82% of its industry peers.
LIVN has a Return On Equity of 1.38%. This is in the better half of the industry: LIVN outperforms 73.85% of its industry peers.
LIVN has a Return On Invested Capital of 2.15%. This is in the better half of the industry: LIVN outperforms 72.31% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for LIVN is significantly below the industry average of 8.50%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.73% | ||
| ROE | 1.38% | ||
| ROIC | 2.15% |
ROA(3y)-3.07%
ROA(5y)-6.05%
ROE(3y)-5.42%
ROE(5y)-11.82%
ROIC(3y)2.61%
ROIC(5y)N/A
1.3 Margins
The Profit Margin of LIVN (1.53%) is better than 72.82% of its industry peers.
LIVN has a better Operating Margin (4.94%) than 71.28% of its industry peers.
LIVN's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 66.86%, LIVN is in the better half of the industry, outperforming 73.33% of the companies in the same industry.
In the last couple of years the Gross Margin of LIVN has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.94% | ||
| PM (TTM) | 1.53% | ||
| GM | 66.86% |
OM growth 3YN/A
OM growth 5Y-9.27%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.64%
GM growth 5Y0.15%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so LIVN is destroying value.
Compared to 1 year ago, LIVN has more shares outstanding
The number of shares outstanding for LIVN has been increased compared to 5 years ago.
The debt/assets ratio for LIVN is higher compared to a year ago.
2.2 Solvency
An Altman-Z score of 1.88 indicates that LIVN is not a great score, but indicates only limited risk for bankruptcy at the moment.
LIVN has a debt to FCF ratio of 14.69. This is a negative value and a sign of low solvency as LIVN would need 14.69 years to pay back of all of its debts.
LIVN's Debt to FCF ratio of 14.69 is fine compared to the rest of the industry. LIVN outperforms 74.36% of its industry peers.
LIVN has a Debt/Equity ratio of 0.44. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.44, LIVN is doing worse than 61.03% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.44 | ||
| Debt/FCF | 14.69 | ||
| Altman-Z | 1.88 |
ROIC/WACC0.26
WACC8.12%
2.3 Liquidity
LIVN has a Current Ratio of 2.95. This indicates that LIVN is financially healthy and has no problem in meeting its short term obligations.
LIVN's Current ratio of 2.95 is in line compared to the rest of the industry. LIVN outperforms 48.21% of its industry peers.
LIVN has a Quick Ratio of 2.51. This indicates that LIVN is financially healthy and has no problem in meeting its short term obligations.
LIVN's Quick ratio of 2.51 is in line compared to the rest of the industry. LIVN outperforms 52.31% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.95 | ||
| Quick Ratio | 2.51 |
3. Growth
3.1 Past
LIVN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 17.08%, which is quite good.
The Earnings Per Share has been decreasing by -4.51% on average over the past years.
Looking at the last year, LIVN shows a quite strong growth in Revenue. The Revenue has grown by 12.88% in the last year.
Measured over the past years, LIVN shows a small growth in Revenue. The Revenue has been growing by 0.83% on average per year.
EPS 1Y (TTM)17.08%
EPS 3Y30.31%
EPS 5Y-4.51%
EPS growth Q2Q7.41%
Revenue 1Y (TTM)12.88%
Revenue growth 3Y7.28%
Revenue growth 5Y0.83%
Revenue growth Q2Q12.82%
3.2 Future
Based on estimates for the next years, LIVN will show a quite strong growth in Earnings Per Share. The EPS will grow by 13.42% on average per year.
LIVN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.66% yearly.
EPS Next Y9%
EPS Next 2Y9.85%
EPS Next 3Y10.4%
EPS Next 5Y13.42%
Revenue Next Year6.85%
Revenue Next 2Y5.77%
Revenue Next 3Y5.58%
Revenue Next 5Y6.66%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
LIVN is valuated rather expensively with a Price/Earnings ratio of 19.76.
Based on the Price/Earnings ratio, LIVN is valued cheaply inside the industry as 86.67% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of LIVN to the average of the S&P500 Index (24.84), we can say LIVN is valued slightly cheaper.
The Price/Forward Earnings ratio is 18.13, which indicates a rather expensive current valuation of LIVN.
Compared to the rest of the industry, the Price/Forward Earnings ratio of LIVN indicates a rather cheap valuation: LIVN is cheaper than 88.21% of the companies listed in the same industry.
LIVN is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 21.35, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.76 | ||
| Fwd PE | 18.13 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, LIVN is valued a bit cheaper than 72.31% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, LIVN is valued a bit cheaper than the industry average as 74.87% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 75.04 | ||
| EV/EBITDA | 30.93 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)2.2
PEG (5Y)N/A
EPS Next 2Y9.85%
EPS Next 3Y10.4%
5. Dividend
5.1 Amount
No dividends for LIVN!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
LIVANOVA PLC
NASDAQ:LIVN (4/26/2024, 7:01:25 PM)
After market: 55.53 0 (0%)55.53
+0.43 (+0.78%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap3.00B
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.76 | ||
| Fwd PE | 18.13 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)2.2
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.73% | ||
| ROE | 1.38% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | 4.94% | ||
| PM (TTM) | 1.53% | ||
| GM | 66.86% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.47
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.44 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 2.95 | ||
| Quick Ratio | 2.51 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)17.08%
EPS 3Y30.31%
EPS 5Y
EPS growth Q2Q
EPS Next Y9%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)12.88%
Revenue growth 3Y7.28%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y